---
title: "Aier Eye Hospital Group Co.,Ltd. (300015.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300015.SZ.md"
symbol: "300015.SZ"
name: "Aier Eye Hospital Group Co.,Ltd."
industry: "Health Care Facilities"
datetime: "2026-05-20T14:41:34.440Z"
locales:
  - [en](https://longbridge.com/en/quote/300015.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300015.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300015.SZ.md)
---

# Aier Eye Hospital Group Co.,Ltd. (300015.SZ)

## Company Overview

Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, Europe, and Southeast Asia. It offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and lens fitting for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery.

| Item | Detail |
|------|--------|
| Industry | Health Care Facilities |
| Exchange | CN Market |
| Website | [www.aierchina.com](https://www.aierchina.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:11.000Z

**Overall: B (0.35)**

**Industry**: Health Care Facilities

| Metric | Value |
|--------|-------|
| Industry Ranking | 1 / 9 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 4.17% |  |
| Net Profit YoY | -9.05% |  |
| P/B Ratio | 4.00 |  |
| Dividend Ratio | 2.42% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 92298799988.23 |  |
| Revenue | 22763376473.50 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 15.02% | A |
| Profit Margin | 14.84% | A |
| Gross Margin | 47.73% | B |
| Revenue YoY | 4.17% | C |
| Net Profit YoY | -9.05% | D |
| Total Assets YoY | 5.77% | C |
| Net Assets YoY | 6.70% | B |
| Cash Flow Margin | 173.84% | B |
| OCF YoY | 4.17% | C |
| Turnover | 0.64 | B |
| Gearing Ratio | 32.72% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Aier Eye Hospital Group Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "4.17%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-9.05%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.00",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "2.42%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "92298799988.23",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "22763376473.50",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "15.02%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "14.84%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "47.73%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "4.17%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-9.05%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "5.77%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "6.70%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "173.84%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "4.17%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.64",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "32.72%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 26.20 | 1/9 | 33.24 | 32.07 | 29.93 |
| PB | 3.83 | 6/9 | 5.40 | 5.00 | 4.33 |
| PS (TTM) | 3.89 | 6/9 | 5.38 | 5.07 | 4.40 |
| Dividend Yield | 2.53% | 1/9 | 2.26% | 1.34% | 1.25% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Aier (300015.SZ) | B | C | B | B | B | B |
| 02 | Sanbo (301293.SZ) | C | B | C | B | A | B |
| 03 | Huaxia Eye (301267.SZ) | B | C | C | B | B | B |
| 04 | INKON Life (300143.SZ) | C | B | C | B | A | B |
| 05 | Innovative Medical (002173.SZ) | D | D | D | A | E | C |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-19T16:00:00.000Z

Total Analysts: **17**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 12 | 71% |
| Overweight | 3 | 18% |
| Hold | 1 | 6% |
| Sell | 1 | 6% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 9.47 |
| Highest Target | 16.00 |
| Lowest Target | 6.50 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300015.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300015.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300015.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300015.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**